Michigan Oncology Quality Consortium (MOQC) Abstraction & MOQC Pathway Fall 2017 September 5 & 7, 2017 6:00-7:30pm
Discussion Topic Time Welcome & Roll Call 15 mins Objectives 5 mins Requirements for Fall 2017 Round 40 mins Pre-Abstraction • Abstraction • Post Abstraction • Questions 20 mins Next Steps 5 mins
Roll Call • Name • Practice • New or Experienced with Abstraction? 3
Objectives At the end of this webinar, you will: 1. Identify the MOQC Pathway 2. Understand MOQC’s expectations for the abstractor role for this round 3. Understand how you or your practice will be paid for abstraction 4. Commit to next steps
For Spring, 2017 THANK YOU!
Three Phases I. Preparation for Abstraction (Pre-Abstraction) II. Abstraction III. Post Abstraction
I. Pre - Abstraction • Attended QOPI webinars – Sign into your QOPI account – Go to QOPI landing page> Round materials and training • #1 QOPI Participant Training Webinar • #2 Abstractor Training Webinar
Your Practice’s Landing Page Practice Name Practice Name and Number
Key Points For MOQC Practices 1. Register Your Practice Ensure you select MOQC Participant under “Demographics” – If you are a new practice that has not entered data into QOPI before, there is an attestation – screen that appears that you must complete 2. Calculate or check that the Number of physician FTES is accurately calculated and entered are correct because is the basis for the number of charts to be abstracted 3. Register for Fall 2017 Round 4. Choose MOQC C Pa Pathway for abstraction 5. Validate your abstractors in QOPI Practice account
Register Your Practice Review each data element under the Red Tile and the Yellow Tile and update to reflect your current practice All must have a green “checkmark” to proceed to Legal Agreement Practice name Practice ID Physician’s Last Name 10
Register As MOQC Practice Practice name This header indicates where in the QOPI program you are Select “Yes” 11
Calculate Physician FTEs Only for physicians – Exclude NP, PA and Fellows Use this template for each physician then Add the numbers up to get Total FTES Monday Tuesday Wednesday Thursday Friday Morning 0.1 0.1 0.1 0.1 0.1 = 1.0 0.1 Afternoon 0.1 0.1 0.1 0.1 12
Calculate Physician FTEs Physician #1 Monday Tuesday Wednesday Thursday Friday Morning X X X X X = 0.8 Afternoon X X X Physician #2 Monday Tuesday Wednesday Thursday Friday Morning X X X X X = 0.5 Afternoon Two physician headcount but a 1.3 FTE Each “X” is a 4 hour block of time that a = 1.3 FTES 13 physician sees patients
Enter Physician FTEs Accurately Staffing and Patient Services Screen Medical/Hematologist Oncologist= a physician that sees both solid tumor and blood cancer patients Hematologist-Oncologist = A physician that sees hematology (cancer and non cancer) patients Number of physicians drives number of unique charts that need to be abstracted from your Medical-Oncologist = A physician practice that sees solid tumor cancer patients and does not see blood cancer patients 14
Register for Round When Completed Red, Yellow and Gray Tiles 15
Select MOQC Pathway All other modules must be “NO” The only exception for a MOQC practice is if practice is submitting data for QOPI certification/ recertification; if this is the case, Select “QCP” instead of MOQC Pathway UN-SELECT TEST MEASURES 16
Update Abstractor List Sign into Practice > Administration >> User Management and add Name 17
Adding or Editing Abstractors Double check that email address is correct or abstractor will NOT receive QOPI password information All * must be complete email address must be • accurate Once complete and checked “save” Select • Person will receive email from “abstractor” from • ASCO-QOPI with user name drop down under and request to set up password “user role” 18
I. Prepare Your Patient List Also known as the “chart selection criteria” Sign into • your account On QOPI • Landing page – see below 19
Prepare List #1 – Fall 2017 Use all ICD-10s to have enough charts Yes Yes Yes Yes Yes Yes Yes
Prepare List #2 – End of Life Use only End of Life Criteria to develop this patient or chart list MOQC is validating if criteria is accurate as of 9/11/2017 as this conflicts with criteria in “red” type 21
NEW - MOQC Pathway 17 QOPI Measures covering six modules 1. Core 2. Breast 3. Colorectal 4. NSCLC 5. Symptom and Toxicity 6. End of Life • Chosen by MOQC oncologists and patients • Provide focus for improvement 22
Page 1 of 2 of MOQC Measures 23
MOQC Pathway Page 2 of 2 24
I. Pre-Abstraction – Final Thoughts Set up two patient lists so you can use for each abstraction round by • updating the query with any changes with: ICD-10s • Dates • New physicians, physician assistants and nurse practitioners • Once list is created, last step is to select charts for abstraction • Select charts/patients from list in a random method (e.g. every 2rd or 3 rd patient) • If you run out of charts, abstract Core charts until unique chart requirement is • completed 25
II. Abstraction • Not documented = not done • Even if you know physician’s practice, you cannot give credit for a measure if there is no evidence of documentation • Keep track of all hours - you will have to report to MOQC • Use MOQC documents for measure detail (called measures specifications) • What is included • What is excluded 26
II. Abstraction MOQC Measures – Important take-aways 1. CORE 6e & End of Life (EOL) 38 – Pain addressed appropriately Both Core and EOL • All pain, not just cancer pain • All three components for pain: • Pain assessed (notation that patient has no pain) • Quantified by some type of scale • Plan of care • 27
MOQC Measures 2. Core 13a1: Stage IV at initial diagnosis or development of mets & solid tumor 3. Core 13o6a Oral chemotherapy – not IV or other route • Initial therapy only • Is medication adherence assessed? • 4. Core 22bb: tobacco cessation assistance provided by practice or patient referred in a year or at most recent office visit • Note: Excludes vaping & e-cigarette use 28
MOQC Measures 5. Core28a: Aprepitant/fosaprepitant (Emend) or netupitant (AKYNZEO) 6. Core33: Infertility risks prior to chemotherapy. What are the inclusive ages for Male, Female? 7. EOL 41: Dyspnea • What other words do providers use for dyspnea? • Dyspnea must be: • Assessed • Addressed or there is documentation that patient did not have dyspnea 29
MOQC Measures MOQC is checking on this timeframe 8. EOL 44: includes day 3 9. EOL 47: date of death to hospice enrollment or palliative care date of discussion < 62 days 10. Breast61: IV bisphosphonates or desnosumab 11. Breast62c1: serum (blood test) tumor marker • CEA • CA15-3 • CA27.29 30
MOQC Measures 12. Colorectal 63: Presence and/or absence of first degree relative • What is a 1 st degree relative? • Age of diagnosis for each relative will be asked by QOPI program during abstraction 13. Colorectal 73: • QOPI will exclude any patient with AJCC Stage IV disease or M-staging at colon or rectal diagnosis • Patient had surgical resection and margins clear or noted as positive (R1, micro or macro positive) 14.NSCLC 89a: Only metastatic disease GCSF include: There are different types of G-CSF, including: • • lenograstim (Granocyte) • filgrastim (Neupogen, Zarzio, Nivestim, Ratiograstim) • long acting (pegylated) filgrastim (pegfilgrastim, Neulasta) and lipegfilgrastim (Longquex) 31
II. Complete MRN-QOPI Crosswalk • Create and keep a cross walk for all abstracted charts, MRN and assigned QOPI number • Required for retrospective audit by MOQC or practice • Form on www.moqc.org/ 32
III. Post Abstraction • Submit hours to MOQC • Independent • Submit hours 48 hours after abstraction round closes, or • When your practice finishes abstraction • MOQC Abstractors (have contract with MOQC) • By Friday September 29 th • By Friday October 27 th • 48 hours after abstraction round closes • Look for practice data, December, 2017 • Receive electronic notice that data available in QOPI • MOQC will send 17 measures by practice by region but de- identified 33
End of Webinar • Next slides only for abstractors subcontracted to MOQC who abstract • Their own practice or • Scheduled by MOQC to practices 34
Recommend
More recommend
